JP2002520281A - 粘膜疾患の局所治療における使用のためのビタミンｅおよびそのエステル - Google Patents

粘膜疾患の局所治療における使用のためのビタミンｅおよびそのエステル

Info

Publication number
JP2002520281A
JP2002520281A JP2000558814A JP2000558814A JP2002520281A JP 2002520281 A JP2002520281 A JP 2002520281A JP 2000558814 A JP2000558814 A JP 2000558814A JP 2000558814 A JP2000558814 A JP 2000558814A JP 2002520281 A JP2002520281 A JP 2002520281A
Authority
JP
Japan
Prior art keywords
mucosa
use according
vitamin
compound
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000558814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002520281A5 (enExample
Inventor
パニン，ジョルジオ
アヌンジアタ，エレオノラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2002520281(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of JP2002520281A publication Critical patent/JP2002520281A/ja
Publication of JP2002520281A5 publication Critical patent/JP2002520281A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
JP2000558814A 1998-07-10 1999-07-05 粘膜疾患の局所治療における使用のためのビタミンｅおよびそのエステル Pending JP2002520281A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
IT98A001586 1998-07-10
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (2)

Publication Number Publication Date
JP2002520281A true JP2002520281A (ja) 2002-07-09
JP2002520281A5 JP2002520281A5 (enExample) 2006-08-24

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000558814A Pending JP2002520281A (ja) 1998-07-10 1999-07-05 粘膜疾患の局所治療における使用のためのビタミンｅおよびそのエステル

Country Status (22)

Country Link
EP (1) EP1094807B1 (enExample)
JP (1) JP2002520281A (enExample)
CN (1) CN1135975C (enExample)
AT (1) ATE238051T1 (enExample)
AU (1) AU762860B2 (enExample)
BR (1) BR9911945A (enExample)
CA (1) CA2336990A1 (enExample)
CZ (1) CZ301019B6 (enExample)
DE (1) DE69907193T2 (enExample)
DK (1) DK1094807T3 (enExample)
ES (1) ES2196813T3 (enExample)
HU (1) HU228921B1 (enExample)
IL (1) IL140759A0 (enExample)
IT (1) ITMI981586A1 (enExample)
NO (1) NO20006719L (enExample)
NZ (1) NZ509129A (enExample)
PL (1) PL345500A1 (enExample)
PT (1) PT1094807E (enExample)
RU (2) RU2221561C2 (enExample)
SK (1) SK284464B6 (enExample)
TR (2) TR200100014T2 (enExample)
WO (1) WO2000002554A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505244A (ja) * 2008-10-09 2012-03-01 ラムズコア， インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
JP2013500302A (ja) * 2009-07-27 2013-01-07 サンセベリノ，レナト Ｕｖ−ａ線に対する眼球内部構造保護用又は経上皮架橋術式による円錐角膜の治療用点眼液
JP2022028975A (ja) * 2015-10-15 2022-02-16 ロート製薬株式会社 異物感改善用眼科組成物

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
RU2428973C2 (ru) * 2005-03-03 2011-09-20 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие липидопонижающими свойствами
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
WO2013049749A2 (en) 2011-09-29 2013-04-04 Plx Pharma Inc. pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
LT3209294T (lt) * 2014-10-22 2019-10-25 Bio Lo Ga Srl Farmacinė kompozicija, skirta panaudoti nosies gleivinės trofizmo padidinimui
JP2018507895A (ja) * 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
WO2020053783A1 (en) * 2018-09-12 2020-03-19 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
KR20220158031A (ko) 2020-03-26 2022-11-29 피엘엑스 옵코 인코포레이티드 pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0640910A (ja) * 1992-05-26 1994-02-15 Santen Pharmaceut Co Ltd ビタミンｅ点眼剤
JPH06293639A (ja) * 1993-04-08 1994-10-21 Lion Corp 安定なビタミンａ類及びビタミンｅ類可溶化点眼剤
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0640910A (ja) * 1992-05-26 1994-02-15 Santen Pharmaceut Co Ltd ビタミンｅ点眼剤
JPH06293639A (ja) * 1993-04-08 1994-10-21 Lion Corp 安定なビタミンａ類及びビタミンｅ類可溶化点眼剤
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012505244A (ja) * 2008-10-09 2012-03-01 ラムズコア， インコーポレイテッド ドライアイ症候群の処置のための組成物および方法
JP2013500302A (ja) * 2009-07-27 2013-01-07 サンセベリノ，レナト Ｕｖ−ａ線に対する眼球内部構造保護用又は経上皮架橋術式による円錐角膜の治療用点眼液
JP2022028975A (ja) * 2015-10-15 2022-02-16 ロート製薬株式会社 異物感改善用眼科組成物
JP2023093761A (ja) * 2015-10-15 2023-07-04 ロート製薬株式会社 異物感改善用眼科組成物
JP2025023354A (ja) * 2015-10-15 2025-02-14 ロート製薬株式会社 異物感改善用眼科組成物

Also Published As

Publication number Publication date
EP1094807B1 (en) 2003-04-23
ITMI981586A1 (it) 2000-01-10
ATE238051T1 (de) 2003-05-15
NZ509129A (en) 2003-10-31
PL345500A1 (en) 2001-12-17
SK352001A3 (en) 2001-06-11
HUP0102781A2 (hu) 2001-12-28
PT1094807E (pt) 2003-08-29
TR200100014T2 (tr) 2001-06-21
RU2003128023A (ru) 2005-04-10
DK1094807T3 (da) 2003-08-11
SK284464B6 (sk) 2005-04-01
WO2000002554A1 (en) 2000-01-20
AU4385899A (en) 2000-02-01
EP1094807A1 (en) 2001-05-02
CN1308531A (zh) 2001-08-15
BR9911945A (pt) 2001-03-27
IL140759A0 (en) 2002-02-10
DE69907193D1 (de) 2003-05-28
AU762860B2 (en) 2003-07-10
ES2196813T3 (es) 2003-12-16
DE69907193T2 (de) 2004-04-08
CZ200136A3 (cs) 2001-08-15
CN1135975C (zh) 2004-01-28
NO20006719D0 (no) 2000-12-29
CZ301019B6 (cs) 2009-10-14
HU228921B1 (en) 2013-06-28
ITMI981586A0 (it) 1998-07-10
RU2221561C2 (ru) 2004-01-20
NO20006719L (no) 2001-02-16
TR200103710T2 (tr) 2002-06-21
CA2336990A1 (en) 2000-01-20
HUP0102781A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
RU2221561C2 (ru) Витамин е и его сложные эфиры для местного лечения патологий слизистой оболочки
JP5118633B2 (ja) 医療用デバイスおよび医薬製剤において有用な粘膜付着性キシログルカン含有製剤
TWI901567B (zh) 胜肽之抗發炎用途
CN115300508A (zh) 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂
EP1503763B1 (en) Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
CN107961232A (zh) 药物调配物和其用途
CN112770765A (zh) 用于预防和/或治疗泌尿生殖器粘膜的组合物
MXPA01000368A (en) Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies
EA002267B1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
Olifirova et al. Possibilities of therapy optimization of patients with superficial burning wounds
JP2004059440A (ja) 肌荒れ防止および粘膜修復剤
WO2025224482A1 (es) Composición a base de acmella oppositifolia y de matricaria chamomilla
JP2024542280A (ja) アラニル－グルタミンおよびアラニル－グルタミンを含む眼科用組成物の新規な使用
Al-Niaimi et al. Pre-existing and coincidental skin disease
JPH08509245A (ja) 乾癬の治療におけるセルレチドジエチルアミン塩の使用
CN104415050A (zh) 一种治疗病毒性疱疹的外用喷雾剂
ITMI20110954A1 (it) Combinazioni per il trattamento delle mucositi vaginali o rettali

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060626

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060626

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091215

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101005